Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (4): 1474-1479–DOI: 10.26355/eurrev_202302_31387–PMID: 36876687 published online on 1 March 2023. This erratum serves to include the ethics approval date and approval number, which were unintentionally omitted from the originally published online version of the article. Therefore, the Ethics Approval statement has been corrected as follows: Institutional […] L'articolo Author Correction: Serum irisin levels in colorectal cancer pat...| European Review
The article “Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A” by J.-X. Ma, Y.-L. Yang, X.-Y. He, X.-M. Pan, Z. Wang, Y.-W. Qian, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4756-4762 DOI: 10.26355/eurrev_201906_18057–PMID: 31210302 has been retracted by in accordance with the Publisher and the […] L'articolo Retraction Note: Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metast...| European Review
From wearables to virtual counselors, artificial intelligence is set to revolutionize mental health support for patients with breast cancer.| UVA Health Newsroom
A biomarker present in 20% of ER+/HER2− breast cancers has been identified, with potential to predict heightened sensitivity to CDK4/6 inhibitor drugs. The post Biomarker Discovery Could Improve Personalized Care in ER+ Breast Cancer appeared first on Inside Precision Medicine.| Inside Precision Medicine
Measuring acoustic emissions from microbubbles during focused ultrasound may help researchers standardize blood-brain barrier opening during glioma treatment. The post Glioma Treatment May Benefit from Acoustic Biomarker–Guided BBB Opening appeared first on Inside Precision Medicine.| Inside Precision Medicine
Tamoxifen fuels uterine cancer by activating the PI3K pathway, according to a new study, bypassing mutations normally required. Findings point to potential strategies to reduce risk while preserving the drug’s breast cancer benefits. The post How Tamoxifen Raises Uterine Cancer Risk—and a Path to Prevention appeared first on Inside Precision Medicine.| Inside Precision Medicine
Triple-negative breast cancer in this population was largely similar to that of Asian American and non-Hispanic white women. The post Triple-Negative Breast Cancer Mutations Mapped in Black Women appeared first on Inside Precision Medicine.| Inside Precision Medicine
The research used CRISPR/Cas9 to develop an in vivo screen of MYC-driven lymphoma in mouse models to show that the loss of NPRL3, DEPDC5, or NPRL2 in the GATOR1 complex significantly accelerates lymphoma development. The post CRISPR Screen Identifies GATOR1 as Lymphoma Tumor Suppressor appeared first on Inside Precision Medicine.| Inside Precision Medicine
A blood test developed by Somerville, Mass.-based Mass General Brigham researchers can accurately identify HPV-associated throat cancers, according to a study published Aug. 14 in Clinical Cancer Research. There are currently no tests to detect early-stage HPV-associated throat cancers, leading most cases to be detected and diagnosed after the cancer has spread to lymph nodes […]| Becker's Hospital Review | Healthcare News & Analysis
Explore the top ranked hospitals offering lung transplant programs The post Top 10 Lung Transplant Hospitals Worldwide appeared first on Medical Travel Market.| Medical Travel Market
Learn about lung transplant costs by country for international patients, including double lung transplant and single, as well as insurance coverage for transplant.| Medical Travel Market
Teal Health has announced the launch of their Teal Wand at-home cervical cancer screening kit and virtual telehealth services in California.| Inside Precision Medicine
Patty Spears: Building Trust and Fostering Communication Directly with Researchers Matters / cancer, Cancer research, innovative cancer research, OncoDaily,| Oncodaily - Oncology News, Insights, Stories
A pilot study shows promise in enhancing shared decision-making and patient satisfaction through family-centered support. | Pediatrics Nationwide
Rachael Larkin, BS, OMS-III1; Michael Bagnoli, DO1; Micah Jones, DO2 1Edward Via College of Osteopathic Medicine 2LewisGale HCA Medical Center Abstract A 61-year-old male presented with a left hamstring avulsion and an incidentally discovered gluteal mass on MRI. Surgical excision confirmed extraskeletal myxoid chondrosarcoma (EMC), managed with adjuvant radiation therapy. Serial imaging showed no recurrence […] The post Incidental Extraskeletal Myxoid Chondrosarcoma of the Left Gluteus M...| AOAO
New research shows how glioblastoma cells infiltrate the brain and which key genes drive the invasion, paving the way to new treatments.| Inside Precision Medicine
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs for the genetic condition neurofibromatosis type 1| The Hub
A new mRNA cancer vaccine, in combination with common immunotherapy drugs, could become the first universal cancer vaccine.| Inside Precision Medicine
Pioneering research ‘fundamentally changed’ our understanding of brain cancer and opened the door to new treatments.| UVA Health Newsroom
The UVA Community Health Foundation announced a $25,000 donation to the UVA Health Cancer Care Gainesville clinic from Heritage Charity Classic.| UVA Health Newsroom
The allogeneic Azer-cel showed impressive response rates in a Phase Ib study with DLBCL patients who had failed autologous CAR T cell therapy treatments.| Inside Precision Medicine
Cancer deaths linked to obesity have tripled in the U.S. over the past two decades, according to a study presented Sunday at ENDO.| Inside Precision Medicine
Genmab, a Danish company focused on developing antibody therapies for patients with cancer, opened a new site in Plainsboro, NJ.| Drug Discovery and Development
UVA Cancer Center is seeking innovative, community-led projects for its 2025 Comprehensive Community Grants program.| UVA Health Newsroom
Artera Launches DIRECT-AI Registry Study to Evaluate Real-World Impact of its AI Prostate Cancer Test to evaluate their long-term cancer...| hitconsultant.net
The goal of precision medicine is to develop individualized treatments based on a patient's genetic profile. Here's how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.| JNJ.com
Integrated cancer care center marks major milestone for patients seeking world-class cancer treatment The post Mayo Clinic Opens First Carbon Ion Therapy Center in the U.S. appeared first on Medical Travel Market.| Medical Travel Market
The UVA Cancer Center Community Advisory Council has developed a community-focused roadmap to reduce cancer’s impact across Virginia and West Virginia.| UVA Health Newsroom
Labcorp rolls out new NGS panels, HRD testing, and a Leica-Proscia digital pathology platform to accelerate biomarker screening.| Drug Discovery and Development
By furthering our investment in women’s cancer datasets, COTA is eager to collaborate with industry partners on accelerating research into these conditions with the goal of improving experiences and outcomes for the hundreds of thousands of women affected by cancer every year.| COTA Healthcare
We’re setting our sights on solid tumors to bring even more clarity and understanding to the cancer community. Our datasets now include longitudinal treatment and outcomes data for a broad array of solid tumors.| COTA Healthcare
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]| COTA Healthcare
Partnership with Japan’s Toshiba ESS-DK Medical Solutions consortium The post Asan Medical Center to Open Korea’s Largest Heavy Ion Radiotherapy Facility by 2031 appeared first on Medical Travel Market.| Medical Travel Market
The $25M regional cancer center in Bullitt County aims to increase access to comprehensive cancer care in south, central and western Kentucky.| UofL Health | Louisville Hospital and Health Care System Serving Kentucky and...
Four UVA Health University Medical Center teams have been honored with national patient experience awards based on top ratings from patients.| UVA Health Newsroom
ISB researchers Drs. Matt Wall, Serdar Turkarslan, Nitin Baliga, and others, along with collaborators, have developed a technology to generate a patient-specific disease-relevance network map to accurately predict risk, personalize therapies, and discover novel drug targets for solid and liquid tumors. The post Baliga Lab researchers and collaborators found that genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma appeared first on Baliga Lab.| Baliga Lab
$1B women's health push and RNAi advances mark JPM 2025, with solid tumor therapies gaining momentum| Drug Discovery and Development
Adding the chemotherapy pill temozolomide to radiation improves survival for adults with grade 2 gliomas, a clinical trial has found.| UVA Health Newsroom
UVA Cancer Center, Appalachian Community Cancer Alliance and Buchanan General Hospital (BGH) have teamed up to make lung cancer screenings easier.| UVA Health Newsroom
A global health care company has cut the ribbon on its new facility and headquarters in Houston.| InnovationMap
Cancer treatment in Houston just became even more promising — and forward-thinking.| InnovationMap
The Dan River Cancer Task Force is refocusing to address cancer disparities in Southside Virginia, focusing on education, prevention and early detection.| UVA Health Newsroom
UVA Cancer Center is seeking innovative, community-based projects to reduce the burden of cancer and enhance health equity.| UVA Health Newsroom
UVA Health Outpatient Imaging Culpeper is proud to unveil a second mammography machine - a new breast biopsy system.| UVA Health Newsroom
Dangerous dusts and malignant mesotheliomas: Q&A with Alison Grimes| blog.dhimmel.com
Elevation, Oxygen, and Cancer of the Lung| blog.dhimmel.com
The Rise of Technological Marvel: AI Unleashes a Paradigm Shift in Oncology Cancer, a condition characterized by the uncontrolled growth| Artificial Intelligence Magazine | AI Webezine